远程药学管理对冠心病伴高血压患者治疗依从性及预后的改善效果研究  

Study on the effect of remote pharmaceutical management on the improvement of treatment compliance and prognosis in patients with coronary heart disease and hypertension

作　　者：冯纪讷[1] 陈伟 李文芬 王成华 赵倩倩 刘伟 孙克浩 谭伟强 高燕芬 FENG Ji'ne;CHEN Wei;LI Wenfen;WANG Chenghua;ZHAO Qianqian;LIU Wei;SUN Kehao;TAN Weiqiang;GAO Yanfen(Department of Cardiology,Linqu People's Hospital,Shandong,Linqu 262600,China;Xinzhai Central Health Center of Linqu County,Shandong,Linqu 262600,China;Jiangyu Central Health Center of Linqu County,Shandong,Linqu 262600,China;Jiushan Central Health Center of Linqu County,Shandong,Linqu 262600,China)

机构地区：[1]山东省临朐县人民医院心内科,山东临朐262600 [2]山东省临朐县辛寨中心卫生院,山东临朐262600 [3]山东省临朐县蒋峪中心卫生院,山东临朐262600 [4]山东省临朐县九山中心卫生院,山东临朐262600

出　　处：《中国医药科学》2021年第19期206-209,共4页China Medicine And Pharmacy

基　　金：山东省医药卫生科技发展计划项目(202003011236)。

摘　　要：目的探究远程药学管理对冠心病伴高血压患者治疗依从性及预后的改善效果。方法选取2019年1月至2020年1月临朐县人民医院收治的86例冠心病伴高血压患者,按照随机数字表法随机分为观察组和对照组,每组各43例。对照组进行常规用药干预,观察组在此基础上给予远程药学管理。比较两组治疗依从性,干预前后控制情况、生活质量改善情况以及干预期间主要不良心血管事件(MACCE)发生率。结果观察组服药依从性、运动训练依从性及生活方式改善依从性均明显高于对照组,差异有统计学意义(P<0.05);干预1年后,观察组收缩压和舒张压明显低于对照组,而血压控制率显著高于对照组,差异有统计学意义(P<0.05)。观察组干预后健康调查简表(SF-36)评分明显高于对照组,干预期间MACCE发生率明显低于对照组,差异有统计学意义(P<0.05)。结论远程药学管理可有效改善冠心病伴高血压患者治疗依从性,提高血压控制率及生活质量并改善预后。Objective To investigate the effect of remote pharmaceutical management on the improvement of treatment compliance and prognosis in patients with coronary heart disease and hypertension.Methods A total of 86 patients with coronary heart disease and hypertension admitted to Linqu People's Hospital from January 2019 to January 2020 were selected and randomly divided into the observation group and the control group according to the random number table method,with 43 cases in each group.The control group was given conventional medication intervention,while the observation group was given remote pharmaceutical management on the basis of conventional medication intervention.The two groups were compared in terms of treatment compliance,control condition and improvement in quality of life before and after intervention,and the incidence of major adverse cardiovascular events(MACCE)during the intervention period.Results The medication compliance,exercise training compliance and lifestyle improvement compliance were significantly better in the observation group than those in the control group,with statistically significant differences(P<0.05).At 1 year after the intervention,the systolic and diastolic blood pressure were significantly lower in the observation group than those in the control group,while blood pressure control rate was significantly higher in the observation group than that in the control group,with statistically significant differences(P<0.05).The 36-item short form health survey(SF-36)scores were significantly higher in the observation group than those in the control group after the intervention,and the incidence of MACCE during the intervention was significantly lower in the observation group than that in the control group,with statistically significant differences(P<0.05).Conclusion Remote pharmaceutical management can effectively improve the treatm ent compliance,blood pressure control rate and quality of life and improve the prognosis in patients with coro nary heart disease and hypertension.

关 键 词：远程医疗 药学管理 冠心病 高血压 依从性 

分 类 号：R95[医药卫生—药学]